Cognitive behavioral therapy adds no value to drug treatment for opioid dependence

January 4, 2013 by Helen Dodson in Psychology & Psychiatry

Cognitive behavioral therapy adds no value to drug treatment for opioid dependence

Credit: Shutterstock

(Medical Xpress)—In a surprise finding, Yale researchers report that adding cognitive behavioral therapy to the most commonly used drug treatment for opioid dependence does not further reduce illicit drug use by patients. The study, which could change how such dependence is viewed and treated in the U.S. healthcare system, appears online in the American Journal of Medicine.

The medication, , has been in use for a decade, and is now prescribed to treat opioid dependence more than any other medication of its kind. Prescription by primary care and office-based physicians accounts for much of this increase. Cognitive behavioral therapy (CBT) is an intervention that has demonstrated effectiveness for many psychiatric conditions and substance use disorders, even beyond the period of treatment, but the impact of combining it with buprenorphine has not been clear until now.

To assess the impact, researchers conducted a involving 141 opioid-dependent patients in a primary care clinic. The patients were divided into two groups: those who received buprenorphine treatment alone under the care of a physician, and those who received the buprenorphine and professionally administered cognitive behavioral therapy.

The two treatments showed similar effectiveness – a significant reduction in self-reported frequency of opioid use. But the group receiving showed no more reduction in use than those receiving buprenorphine and physician care.

This finding contrasts with earlier studies that demonstrated improved outcomes with counseling services in patients receiving . But the Yale team notes that the key to success in the non-CBT group was that they were still under a primary physician's care while receiving buprenorphine – even if there was only a limited amount of counseling provided.

"This study demonstrates that some patients can do very well with buprenorphine and minimal physician support. This treatment represents an important tool to help reduce the adverse impact of addiction, HIV, and overdose due to heroin and prescription opioids," said lead author Dr. David A. Fiellin, professor of medicine, investigative medicine, and public health at Yale School of Medicine.

Journal reference: American Journal of Medicine search and more info website

Provided by Yale University search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Storm chasers: born to be wild?

(HealthDay)—We've all seen them: the surfers who race to the beach when a hurricane hits, the guy who decides to ride out the storm in his overmatched boat, the tornado chasers who fearlessly steer their ...

Psychology & Psychiatry created 1 hour ago | popularity not rated yet | comments 0

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Psychology & Psychiatry created 2 hours ago | popularity not rated yet | comments 0 | with audio podcast

Are there atheists in foxholes? Study says they're the minority

Ernie Pyle – an iconic war correspondent in World War II – reportedly said "There are no atheists in foxholes." A new joint study between two brothers at Cornell and Virginia Wesleyan found that only ...

Psychology & Psychiatry created 5 hours ago | popularity 2.5 / 5 (4) | comments 1

Breathing exercises help veterans find peace after war, scholar says

(Medical Xpress)—Research by Stanford scholar Emma Seppala at the Center for Compassion and Altruism Research and Education found that post-traumatic stress disorder decreased in veterans who participated ...

Psychology & Psychiatry created 5 hours ago | popularity not rated yet | comments 0

Depression raises diabetics' risk of severe low blood sugar episodes

(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...

Psychology & Psychiatry created 6 hours ago | popularity not rated yet | comments 0 | with audio podcast


Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Pollen count apps for smartphones are nothing to sneeze at

Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.

Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

About one in four uninsured could be excluded from ACA

(HealthDay)—More than one in four of those eligible for new premium assistance tax credits under the Affordable Care Act (ACA) do not have a checking account and will not be able to receive premiums from ...

ACOG: Hormone therapy not recommended to prevent CHD

(HealthDay)—Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists (ACOG) published ...